# Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

> **NCT01604395** · — · RECRUITING · sponsor: **LG Chem** · enrollment: 6000 (estimated)

## Conditions studied

- Growth Hormone Deficiency
- Turner Syndrome
- Chronic Renal Failure
- Small for Gestational Age
- Idiopathic Short Stature

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01604395
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2012-01
- **Primary completion:** 2032-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604395, "Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01604395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*